‘The Partner Pay Gap – Associations between Spouses’ Relative Earnings and Life Satisfaction among Couples in the UK

Despite women’s recent gains in education and employment, husbands still tend to out-earn their wives. This article examines the relationship between the partner pay gap, i.e. the difference in earned income between married, co-resident partners, and life satisfaction. Contrary to previous studies, we investigate the effects of recent changes in relative earningswithin couples as well as labour market transitions. Using several waves of the UK Household Longitudinal Study, we reveal that men exhibit an increase in life satisfaction in response to a recent increase in their proportional earnings relative to their wives’ earnings. For women, changes in proportional earnings had no effect on life satisfaction. We also find secondary-earning husbands report lower average life satisfaction than majority-earning and equal-earning men, while such differences were not found for women. The analysis offers compelling evidence of the ongoing role of gendered norms in the sustenance of the partner pay gap

The Influence of Changing Hours of Work on Women’s Life-Satisfaction

This paper asks whether moving to part-time work makes women happy. Previous research on labour supply has assumed that as workers freely choose their optimal working hours on the basis of their innate preferences and the hourly wage rate, outcome reflects preference. This paper tests this assumption by measuring the impact of changes in working-hours on life satisfaction in two countries (the UK and Germany using the German Socio-Economic Panel and the British Household Panel Survey). We find decreases in working-hours bring about positive and significant improvement on well-being for women

Environmentally Benign Stab Detonators

Many energetic systems can be activated via mechanical means. Percussion primers in small caliber ammunition and stab detonators used in medium caliber ammunition are just two examples. Current medium caliber (20-60mm) munitions are detonated through the use of impact sensitive stab detonators. Stab detonators are very sensitive and must be small, as to meet weight and size limitations. A mix of energetic powders, sensitive to mechanical stimulus, is typically used to ignite such devices. Stab detonators are mechanically activated by forcing a firing pin through the closure disc of the device and into the stab initiating mix. Rapid heating caused by mechanically driven compression and friction of the mixture results in its ignition. The rapid decomposition of these materials generates a pressure/temperature pulse that is sufficient to initiate a transfer charge, which has enough output energy to detonate the main charge. This general type of ignition mix is used in a large variety of primers, igniters, and detonators.[1] Common primer mixes, such as NOL-130, are made up of lead styphnate (basic) 40%, lead azide (dextrinated) 20%, barium nitrate 20%, antimony sulfide 15%, and tetrazene 5%.[1] These materials pose acute and chronic toxicity hazards during mixing of the composition and later in the item life cycle after the item has been field functioned. There is an established need to replace these mixes on toxicity, health, and environmental hazard grounds. This effort attempts to demonstrate that environmentally acceptable energetic solgel coated flash metal multilayer nanocomposites can be used to replace current impact initiated devices (IIDs), which have hazardous and toxic components. Successful completion of this project will result in IIDs that include innocuous compounds, have sufficient output energy for initiation, meet current military specifications, are small, cost competitive, and perform as well as or better than current devices. We expect flash metal multilayer and sol-gel to be generic technologies applicable to a wide range of devices, especially in small caliber ammunition and sub-munitions. We will replace the NOL-130 mixture with a nanocomposite that consists of a mechanically robust energetic multilayer foil that has been coated with a sol-gel energetic material. The exothermic reactions are activated in this nanocomposite are the transformation of the multilayer material to its respective intermetallic alloy and the thermite reaction, which is characterized by very high temperatures, a small pressure pulse, and hot particle ejection. The proposed materials and their reaction products consist of, but are not limited to aluminum, nickel, iron, aluminum oxide, titanium, iron oxide and boron. These materials have much more desirable environmental and health characteristics than the NOL-130 composition

Amidated Dopamine Neuron Stimulating Peptide Restoration of Mitochondrial Activity

The present invention relates to the use of novel proteins, referred to herein as amidated glial cell line-derived neurotrophic factor (GDNF) peptides (or “Amidated Dopamine Neuron Stimulating peptides (ADNS peptides)”), for treating brain diseases and injuries that result in dopaminergic deficiencies and mitochodrial dysfunction, e.g., reduced complex I enzyme activity

Method of Treating Parkinson\u27s Disease in Humans by Convection-Enhanced Infusion of Glial Cell-Line Derived Neurotrophic Factor to the Putamen

A method of treating Parkinson\u27s disease in humans is disclosed, wherein glial cell-line derive neurotrophic factor (GDNF) is chronically administered directly to one or both putamen of a human in need of treatment thereof via convection-enhanced infusion using at least one implantable pump and at least one catheter. In one aspect of the present invention the GDNF is infused directly into one or both putamen through one or more indwelling intraparenchymal mutitiport brain catheters connected to one or more implantable pumps wherein the flow rate is pulsed

Amidated Dopamine Neuron Stimulating Peptides for CNS Dopaminergic Upregulation

The present invention relates to novel proteins, referred to herein as amidated glial cell line-derived neurotrophic factor (GDNF) peptides (or Amidated Dopamine Neuron Stimulating peptides (ADNS peptides) ), that are useful for treating brain diseases and injuries that result in dopaminergic deficiencies

Method of Treating Parkinson\u27s Disease in Humans by Convection-Enhanced Infusion of Glial Cell-Line Derived Neurotrophic Factor to the Putamen

A method of treating Parkinson\u27s disease in humans is disclosed, wherein glial cell-line derive neurotrophic factor (GDNF) is chronically administered directly to one or both putamen of a human in need of treatment thereof via convection-enhanced infusion using at least one implantable pump and at least one catheter. In one aspect of the present invention the GDNF is infused directly into one or both putamen through one or more indwelling intraparenchymal multiport brain catheters connected to one or more implantable pumps wherein the flow rate is pulsed